Compound 1315
Identifiers
- Canonical SMILES:
CCOc1cc(ccc1C1=N[C@H]([C@H](N1C(=O)N1CCC(CC1)N1CCCC1)c1ccc(Cl)cc1)c1ccc(Cl)cc1)C(C)(C)C
- IUPAC name:
[(4S,5R)-2-(4-tert-butyl-2-ethoxyphenyl)-4,5-bis(4-chlorophenyl)-4,5-dihydroimidazol-1-yl]-(4-pyrrolidin-1-ylpiperidin-1-yl)methanone
- InChi:
InChI=1S/C37H44Cl2N4O2/c1-5-45-32-24-27(37(2,3)4)12-17-31(32)35-40-33(25-8-13-28(38)14-9-25)34(26-10-15-29(39)16-11-26)43(35)36(44)42-22-18-30(19-23-42)41-20-6-7-21-41/h8-17,24,30,33-34H,5-7,18-23H2,1-4H3/t33-,34+/m0/s1
- InChiKey:
MUZXBHMGLOTTHE-SZAHLOSFSA-N
External links
![]() 11549304 |
![]() 9724083 |
External search
![]() |
![]() |
![]() |
![]() |
![]() |
Bibliography (1)
Publication | Name |
---|---|
Nader Fotouhi, Gregory Jay Haley, Klaus B. Simonsen, Binh Thanh Vu, Stephen Evan Webber, F.Hoffmann-La Roche Ag. . Novel cis-imidazolines None. | 74 |
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
1 | 0 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|---|---|---|
MDM2-Like / P53 | 7.62 | cancer | Inhibition |
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 646.28 g/mol | |||
HBA | 6 | |||
HBD | 0 | |||
HBA + HBD | 6 | |||
AlogP | 8.17 | |||
TPSA | 48.38 | |||
RB | 7 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 1 | 0 | 0 | 0 |
Pharmacological data
Bibliography | Name | Target | Competition | Assay type | Assay name | Cell line | Activity type | Activity |
---|---|---|---|---|---|---|---|---|
WO2005110996 | 74 | MDM2 Q00987 |
|
Biochemical assay | Time-Resolved FRET | pIC50 (half maximal inhibitory concentration, -log10) | 7.62 |
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
0.8342 | Cis-[4,5-Bis-(4-Chlorophenyl)-2-(2-Isopropoxy-4-Methoxyphenyl)-4,5-Dihyd Roimidazol-1-Yl]-Piperazin-1-Yl-Methanone | DB04144 | |
0.8271 | RO-5045337 | DB14793 | |
0.7419 | Cis-[4,5-Bis-(4-Bromophenyl)-2-(2-Ethoxy-4-Methoxyphenyl)-4,5-Dihydroimidazol-1-Yl]-[4-(2-Hydroxyethyl)Piperazin-1-Yl]Methanone | DB02872 | |
0.3919 | (6S)-2-amino-6-(3'-methoxybiphenyl-3-yl)-3,6-dimethyl-5,6-dihydropyrimidin-4(3H)-one | DB07874 | |
0.3910 | PCO-371 | DB14946 | |
0.3908 | Sorbinil | DB02712 | |
0.3861 | Pimavanserin | DB05316 | |
0.3843 | Irbesartan | DB01029 | |
0.3796 | Idanpramine | DB13276 | |
0.3760 | Atecegatran metoxil | DB12507 | |
0.3731 | Metralindole | DB09306 | |
0.3707 | Fidarestat | DB02021 | |
0.3707 | (S,R)-fidarestat | DB02101 | |
0.3699 | A-98881 | DB02804 | |
0.3672 | Saredutant | DB06660 |